comparemela.com

Latest Breaking News On - Prelude corporation - Page 6 : comparemela.com

PreludeDx™ Presents New DCISionRT® Data on the Effectiveness of Endocrine Therapy in DCIS Patients at the ASCO 2022 Annual Meeting

/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced compelling.

Mccormick-place
Illinois
United-states
Chicago
American
Pat-whitworth
Dan-forche
Andrew-wade
Cory-dunn
Instagram
Linkedin
Prnewswire-prelude-corporation-preludedx

PreludeDx™ to Present DCIS Study Results Assessing Benefit of Adjuvant Endocrine Therapy Using DCISionRT® During Oral Presentation at ASCO 2022 Annual Meeting

/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today that.

Mccormick-place
Illinois
United-states
Chicago
American
Pat-whitworth
Dan-forche
Andrew-wade
Cory-dunn
Instagram
Linkedin
Prnewswire-prelude-corporation-preludedx

PreludeDx™ to Present DCISionRT® and Novel Residual Risk Subtype Study Results During Scientific Oral Session at ASBrS 2022 Annual Meeting

/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today that.

Australia
United-states
Pat-whitworth
G-bruce-mann
Andrew-wade
Cory-dunn
Frank-vicini
Instagram
Linkedin
Prnewswire-prelude-corporation-preludedx
National-cancer-institute
Nashville-breast-center

PreludeDx™ Closes $20 Million in Funding to Advance Growth Initiatives and Development of Its Precision Medicine Portfolio

/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that.

United-states
Dan-forche
Andrew-wade
Alejandro-sanchez
Cory-dunn
Instagram
Evidity-health-capital
Linkedin
National-cancer-institute
Prelude-corporation-preludedx
Prelude-corporation
Facebook

PreludeDx™ Announces the Appointment of Derek J. Maetzold of Castle Biosciences to its Board of Directors

PreludeDx™ Announces the Appointment of Derek J. Maetzold of Castle Biosciences to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace

California
United-states
University-of-california-san-francisco
Laguna-hills
Dan-forche
Preludedx-dcision
Castle-biosciences
Andrew-wade
Derekj-maetzold
Cory-dunn
Instagram
University-of-california

vimarsana © 2020. All Rights Reserved.